Institutional investors purchased a net $6.3 million shares of CYTR during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 29.84% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
QVT FINANCIAL LP Bought 3.1 Million shares of CytRx Corp